BNP/PUT/INTUITIVE SURGICAL/300/0.1/16.01.26 Stock

Warrant

DE000PC1FYT5

Market Closed - Boerse Frankfurt Warrants 15:50:30 2024-07-02 EDT
1.42 EUR +0.71% Intraday chart for BNP/PUT/INTUITIVE SURGICAL/300/0.1/16.01.26
Current month+4.38%
1 month-25.13%
Date Price Change
24-07-02 1.43 +1.42%
24-07-01 1.41 +2.92%
24-06-28 1.37 0.00%
24-06-27 1.37 +0.74%
24-06-26 1.36 +0.74%

Real-time Boerse Frankfurt Warrants

Last update July 02, 2024 at 03:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1FYT
ISINDE000PC1FYT5
Date issued 2023-12-08
Strike 300 $
Maturity 2026-01-16 (563 Days)
Parity 10 : 1
Emission price 3.64
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.45
Lowest since issue 1.33
Delta-0.12x
Omega 3.360
Premium35.12x
Gearing28.66x
Moneyness 0.6837
Difference Strike -138.8 $
Difference Strike %-46.27%
Spread 0.03
Spread %2.08%
Theoretical value 1.425
Implied Volatility 39.06 %
Total Loss Probability 75.92 %
Intrinsic value 0.000000
Present value 1.425
Break even 284.69 €
Theta-0.02x
Vega0.1x
Rho-0.1x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
438.8 USD
Average target price
428.1 USD
Spread / Average Target
-2.44%
Consensus